Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 214

Similar articles for PubMed (Select 22928005)

1.

Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies.

Ardanuy C, Marimón JM, Calatayud L, Giménez M, Alonso M, Grau I, Pallarés R, Pérez-Trallero E, Liñares J.

PLoS One. 2012;7(8):e43619. doi: 10.1371/journal.pone.0043619. Epub 2012 Aug 22.

2.

Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.

Muñoz-Almagro C, Ciruela P, Esteva C, Marco F, Navarro M, Bartolome R, Sauca G, Gallés C, Morta M, Ballester F, Raga X, Selva L; Catalan study group of invasive pneumococcal disease.

J Infect. 2011 Aug;63(2):151-62. doi: 10.1016/j.jinf.2011.06.002. Epub 2011 Jun 12.

PMID:
21679725
3.

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.

Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF.

Vaccine. 2013 Dec 16;31(52):6232-8. doi: 10.1016/j.vaccine.2013.10.032. Epub 2013 Oct 29.

PMID:
24176490
4.

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.

Demczuk WH, Martin I, Griffith A, Lefebvre B, McGeer A, Lovgren M, Tyrrell GJ, Desai S, Sherrard L, Adam H, Gilmour M, Zhanel GG; Toronto Bacterial Diseases Network; Canadian Public Health Laboratory Network.

Can J Microbiol. 2013 Dec;59(12):778-88. doi: 10.1139/cjm-2013-0614. Epub 2013 Oct 21.

PMID:
24313450
5.

Serotype epidemiology of invasive pneumococcal disease in Swiss adults: a nationwide population-based study.

Meichtry J, Born R, Küffer M, Zwahlen M, Albrich WC, Brugger SD, Mühlemann K, Hilty M.

Vaccine. 2014 Sep 8;32(40):5185-91. doi: 10.1016/j.vaccine.2014.07.060. Epub 2014 Jul 28.

6.

Epidemiology of invasive pneumococcal disease among adult patients in barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007.

Ardanuy C, Tubau F, Pallares R, Calatayud L, Domínguez MA, Rolo D, Grau I, Martín R, Liñares J.

Clin Infect Dis. 2009 Jan 1;48(1):57-64. doi: 10.1086/594125.

7.

Expansion of serotype coverage in the universal pediatric vaccination calendar: short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain.

Picazo J, Ruiz-Contreras J, Casado-Flores J, Negreira S, García-de-Miguel MJ, Hernández-Sampelayo T, Otheo E, Méndez C; HERACLES Study Group.

Clin Vaccine Immunol. 2013 Oct;20(10):1524-30. doi: 10.1128/CVI.00239-13. Epub 2013 Aug 7.

9.
10.

Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era.

Kendall BA, Dascomb KK, Mehta RR, Mason EO, Ampofo K, Pombo DJ, Pavia AT, Byington CL.

Vaccine. 2011 Nov 15;29(49):9123-6. doi: 10.1016/j.vaccine.2011.10.009. Epub 2011 Oct 14.

PMID:
22001280
11.

Molecular epidemiology of serotype 19A Streptococcus pneumoniae among invasive isolates from Alaska, 1986-2010.

Rudolph K, Bruce MG, Bulkow L, Zulz T, Reasonover A, Harker-Jones M, Hurlburt D, Hennessy TW.

Int J Circumpolar Health. 2013 Aug 5;72. doi: 10.3402/ijch.v72i0.20854. eCollection 2013.

12.

Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L.

BMC Infect Dis. 2012 Sep 7;12:207. doi: 10.1186/1471-2334-12-207. Review.

13.

Invasive pneumococcal disease in healthy adults: increase of empyema associated with the clonal-type Sweden(1)-ST306.

Grau I, Ardanuy C, Calatayud L, Rolo D, Domenech A, Liñares J, Pallares R.

PLoS One. 2012;7(8):e42595. doi: 10.1371/journal.pone.0042595. Epub 2012 Aug 13.

14.
15.

Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Mar 12;59(9):253-7.

16.

Dynamics of the pneumococcal population causing acute exacerbations in COPD patients in a Barcelona hospital (2009-12): comparison with 2001-04 and 2005-08 periods.

Domenech A, Ardanuy C, Tercero A, García-Somoza D, Santos S, Liñares J.

J Antimicrob Chemother. 2014 Apr;69(4):932-9. doi: 10.1093/jac/dkt476. Epub 2013 Dec 8.

17.

Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar.

Picazo J, Ruiz-Contreras J, Casado-Flores J, Giangaspro E, Del Castillo F, Hernández-Sampelayo T, Otheo E, Balboa F, Ríos E, Méndez C; Heracles Study Group.

Clin Vaccine Immunol. 2011 Jan;18(1):89-94. doi: 10.1128/CVI.00317-10. Epub 2010 Nov 3.

18.

Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.

Kaplan SL, Barson WJ, Lin PL, Romero JR, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Mason EO Jr.

Pediatr Infect Dis J. 2013 Mar;32(3):203-7. doi: 10.1097/INF.0b013e318275614b.

PMID:
23558320
19.

Decreasing incidence and changes in serotype distribution of invasive pneumococcal disease in persons aged under 18 years since introduction of 10-valent and 13-valent conjugate vaccines in Portugal, July 2008 to June 2012.

Aguiar SI, Brito MJ, Horacio AN, Lopes JP, Ramirez M, Melo-Cristino J; Portuguese Group for the Study of Streptococcal Infections; Portuguese Study Group of Invasive Pneumococcal Disease of the Paediatric Infectious Disease Society.

Euro Surveill. 2014 Mar 27;19(12):20750.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk